CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade CSPC Pharmaceutical Group Limited - 1093 CFD

    6.45
    0%
    0.30
    Low: 6.3
    High: 6.45
    Market Trading Hours* (UTC) Opens on Tuesday at 01:30

    Mon - Fri: 01:30 - 04:00 05:00 - 08:00

    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.30
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.025927 %
    Charges from full value of position ($-4.93)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.025927%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.00401 %
    Charges from full value of position ($0.76)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.00401%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency HKD
    Margin 5%
    Stock exchange Hong Kong
    Commission on trade 0%

    *Information provided by Capital.com

    CSPC Pharmaceutical Group Ltd ESG Risk Ratings

    High Medium Low Negligible

    ‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 6.45
    Open* 6.4
    1-Year Change* -21.47%
    Day's Range* 6.3 - 6.45
    52 wk Range 5.20-10.06
    Average Volume (10 days) 50.06M
    Average Volume (3 months) 996.87M
    Market Cap 81.54B
    P/E Ratio 12.25
    Shares Outstanding 11.90B
    Revenue 34.32B
    EPS 0.56
    Dividend (Yield %) 3.64964
    Beta 0.57
    Next Earnings Date Nov 30, 2023

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Dec 11, 2023 6.30 -0.05 -0.79% 6.35 6.50 6.30
    Dec 8, 2023 6.45 0.00 0.00% 6.45 6.50 6.40
    Dec 7, 2023 6.40 -0.25 -3.76% 6.65 6.65 6.30
    Dec 6, 2023 6.70 0.10 1.52% 6.60 6.75 6.60
    Dec 5, 2023 6.60 -0.10 -1.49% 6.70 6.85 6.55
    Dec 4, 2023 6.70 -0.35 -4.96% 7.05 7.10 6.60
    Dec 1, 2023 7.00 0.10 1.45% 6.90 7.20 6.90
    Nov 30, 2023 6.85 0.00 0.00% 6.85 7.00 6.75
    Nov 29, 2023 6.80 -0.15 -2.16% 6.95 7.05 6.80
    Nov 28, 2023 6.95 0.20 2.96% 6.75 7.00 6.65
    Nov 27, 2023 6.70 -0.15 -2.19% 6.85 6.85 6.65
    Nov 24, 2023 6.80 0.05 0.74% 6.75 6.85 6.75
    Nov 23, 2023 6.85 0.15 2.24% 6.70 6.90 6.60
    Nov 22, 2023 6.70 0.00 0.00% 6.70 6.70 6.60
    Nov 21, 2023 6.70 -0.20 -2.90% 6.90 6.90 6.70
    Nov 20, 2023 6.85 0.15 2.24% 6.70 6.90 6.65
    Nov 17, 2023 6.65 0.10 1.53% 6.55 6.70 6.55
    Nov 16, 2023 6.60 -0.40 -5.71% 7.00 7.00 6.55
    Nov 15, 2023 7.05 0.20 2.92% 6.85 7.05 6.75
    Nov 14, 2023 6.65 -0.05 -0.75% 6.70 6.80 6.60

    CSPC Pharmaceutical Group Limited Events

    Time (UTC) Country Event
    Wednesday, March 20, 2024

    Time (UTC)

    10:59

    Country

    CN

    Event

    Full Year 2023 CSPC Pharmaceutical Group Ltd Earnings Release
    Full Year 2023 CSPC Pharmaceutical Group Ltd Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 30936.9 27866.9 24942.2 22103.2 17716.5
    Revenue 30936.9 27866.9 24942.2 22103.2 17716.5
    Cost of Revenue, Total 8680.49 6731.78 6256.88 6192.21 5979.19
    Gross Profit 22256.4 21135.1 18685.3 15911 11737.4
    Total Operating Expense 23314.4 21034.6 18552.5 17503 13893.6
    Selling/General/Admin. Expenses, Total 11484.5 11457.3 10361.5 9460.59 6841.1
    Research & Development 3986.52 3432.59 2889.84 2000.43 1342.1
    Interest Expense (Income) - Net Operating -461.56 -352.319 -506.452 -83.303 -112.822
    Unusual Expense (Income) 31.401 23.421 -320.669 132.396 16.02
    Other Operating Expenses, Total -407.021 -258.231 -128.57 -199.311 -172.01
    Operating Income 7622.55 6832.32 6389.72 4600.18 3822.96
    Interest Income (Expense), Net Non-Operating -40.286 14.779 1.3 25.981 -30.783
    Net Income Before Taxes 7582.26 6847.1 6391.02 4626.16 3792.18
    Net Income After Taxes 6232.05 5688.12 5229.01 3733.35 3058.42
    Minority Interest -140.66 -82.939 -69.355 -19.246 22.383
    Net Income Before Extra. Items 6091.39 5605.19 5159.65 3714.11 3080.8
    Net Income 6091.39 5605.19 5159.65 3714.11 3080.8
    Income Available to Common Excl. Extra. Items 6091.39 5605.19 5159.65 3714.11 3080.8
    Income Available to Common Incl. Extra. Items 6091.39 5605.19 5159.65 3714.11 3080.8
    Diluted Net Income 6091.39 5605.19 5159.65 3714.11 3080.8
    Diluted Weighted Average Shares 11918.5 11953.8 11955.5 11956.8 11984.8
    Diluted EPS Excluding Extraordinary Items 0.51109 0.4689 0.43157 0.31063 0.25706
    Dividends per Share - Common Stock Primary Issue 0.18547 0.14667 0.10732 0.0931 0.08231
    Diluted Normalized EPS 0.51325 0.47053 0.40963 0.31956 0.25814
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 8027.14 8053.27 7441.39 7885.49 7736.13
    Revenue 8027.14 8053.27 7441.39 7885.49 7736.13
    Cost of Revenue, Total 2308.1 2534.67 2267.28 2141.67 2208.61
    Gross Profit 5719.04 5518.6 5174.11 5743.82 5527.52
    Total Operating Expense 6118.49 6251.14 5435.82 5996.87 5768.24
    Selling/General/Admin. Expenses, Total 2687.35 2750.68 2522.28 3013 2890.8
    Research & Development 1295.96 1007.65 1066.27 1036.17 982.56
    Interest Expense (Income) - Net Operating -168.775 50.09 -216.558 -61.47 -230.044
    Unusual Expense (Income) 23.659 -16.485 0.299 0
    Other Operating Expenses, Total -27.809 -91.947 -186.96 -132.81 -83.681
    Operating Income 1908.65 1802.13 2005.56 1888.63 1967.89
    Interest Income (Expense), Net Non-Operating -8.059 -21.166 -20.369 -11.018 -12.351
    Net Income Before Taxes 1900.59 1780.96 1985.19 1877.61 1955.54
    Net Income After Taxes 1588.94 1469.1 1661.1 1543.86 1592.79
    Minority Interest -50.796 -40.257 -37.552 -42.23 -31.106
    Net Income Before Extra. Items 1538.14 1428.84 1623.55 1501.63 1561.69
    Net Income 1538.14 1428.84 1623.55 1501.63 1561.69
    Income Available to Common Excl. Extra. Items 1538.14 1428.84 1623.55 1501.63 1561.69
    Income Available to Common Incl. Extra. Items 1538.14 1428.84 1623.55 1501.63 1561.69
    Diluted Net Income 1538.14 1428.84 1623.55 1501.63 1561.69
    Diluted Weighted Average Shares 11869.6 11917 11919.3 11918.7 11918.7
    Diluted EPS Excluding Extraordinary Items 0.12959 0.1199 0.13621 0.12599 0.13103
    Dividends per Share - Common Stock Primary Issue 0.12955 0 0.09715 0 0.08537
    Diluted Normalized EPS 0.13125 0.1199 0.13506 0.12601 0.13103
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 23957.2 20336.5 15921.4 13697 13803.5
    Cash and Short Term Investments 13795.7 10727.1 8794.67 5956.93 6628.42
    Cash 8000.85 9283.64 7259.46 4118.24 4335.61
    Short Term Investments 5794.86 1443.41 1535.21 1838.69 2292.81
    Total Receivables, Net 6836.21 6548.65 4744.78 4450.74 3629.18
    Accounts Receivable - Trade, Net 4104.5 3409.28 2543.12 2399.03 2128.37
    Total Inventory 2554.86 2480.37 1861.07 2535.74 3045.32
    Prepaid Expenses
    Other Current Assets, Total 770.379 580.425 520.86 753.545 500.566
    Total Assets 41769.8 34741.6 30070.2 26318.3 23216.8
    Property/Plant/Equipment, Total - Net 10976.9 9563.92 8934.34 9282.38 6692.22
    Property/Plant/Equipment, Total - Gross 15596.2 13426.6 12177.1 12572.5 9495.94
    Accumulated Depreciation, Total -4619.31 -3862.7 -3242.73 -3290.1 -2803.72
    Goodwill, Net 234.904 149.983 149.983 188.964 140.752
    Intangibles, Net 1908.11 467.854 508.742 1135.66 806.986
    Long Term Investments 3783.08 3356.49 3175.62 1485.71 898.542
    Other Long Term Assets, Total 909.596 612.871 622.827 378.223 874.849
    Total Current Liabilities 8958 7226.04 6301.84 6236.77 7247.02
    Accounts Payable 1703.49 1481.36 1204.57 1110.88 1619.36
    Accrued Expenses 728.165 519.256 385.881 371.337 445.834
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 295.555 38.424 223.835 97.235 70.589
    Other Current Liabilities, Total 6230.79 5187 4487.56 4657.32 5111.24
    Total Liabilities 11572.2 8754.9 7737.92 7856.6 8164.58
    Total Long Term Debt 286.989 55.62 92.879 90.3 0
    Long Term Debt 28.95 0
    Deferred Income Tax 611.993 381.484 320.444 304.427 237.917
    Minority Interest 1444.34 841.559 768.785 1056.44 477.34
    Other Liabilities, Total 270.917 250.198 253.968 168.656 202.303
    Total Equity 30197.5 25986.7 22332.3 18461.7 15052.3
    Common Stock 10899.4 10899.4 10899.4 10899.4 10899.4
    Additional Paid-In Capital 196.574 46.794 46.794 46.794 46.794
    Retained Earnings (Accumulated Deficit) 19163.2 15154.5 11523 7406 4055.03
    Other Equity, Total 22.047 -28.446 -36.246 -26.906 -2.403
    Total Liabilities & Shareholders’ Equity 41769.8 34741.6 30070.2 26318.3 23216.8
    Total Common Shares Outstanding 11933.2 11950 11973.8 11973.8 11973.8
    Unrealized Gain (Loss) 237.134 53.423
    Capital Lease Obligations 258.039 55.62 92.879 90.3 0
    Treasury Stock - Common -83.71 -85.6 -100.706 -100.706 0
    Note Receivable - Long Term 0 253.953 757.331 150.432
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total Current Assets 24381.6 23957.2 22828.5
    Cash and Short Term Investments 12090.7 13872.9 13408.8
    Cash 10298 9064.22
    Short Term Investments 1625.43 3574.86 4344.54
    Total Receivables, Net 8879.42 6836.21 6229.46
    Accounts Receivable - Trade, Net 5748.08 4104.5 4009.2
    Total Inventory 2751.95 2554.86 2624.3
    Other Current Assets, Total 659.499 693.224 565.944
    Total Assets 43673.2 41769.8 38838.5
    Property/Plant/Equipment, Total - Net 11358.6 10976.9 10078.4
    Goodwill, Net 234.904 234.904 221.591
    Intangibles, Net 2264.52 1908.11 1464.22
    Long Term Investments 4719.03 3783.08 3084.78
    Note Receivable - Long Term 0 269.365
    Other Long Term Assets, Total 714.633 909.596 891.66
    Total Current Liabilities 9025.67 8958 8459.25
    Accounts Payable 2028.8 1703.49 1675.36
    Accrued Expenses 728.165
    Notes Payable/Short Term Debt 0 0 0
    Current Port. of LT Debt/Capital Leases 208.477 295.555 477.111
    Other Current Liabilities, Total 6788.4 6230.79 6306.78
    Total Liabilities 11853.8 11572.2 10797.2
    Total Long Term Debt 206.785 286.989 205.449
    Capital Lease Obligations 186.885 258.039 193.659
    Deferred Income Tax 556.576 611.993 516.071
    Minority Interest 1692.41 1444.34 1373.84
    Other Liabilities, Total 372.317 270.917 242.602
    Total Equity 31819.5 30197.5 28041.3
    Common Stock 10899.4 10899.4 10899.4
    Additional Paid-In Capital 290.825 196.574 110.38
    Retained Earnings (Accumulated Deficit) 20934.8 19163.2 17099.2
    Treasury Stock - Common -334.67 -83.71 -83.71
    ESOP Debt Guarantee
    Other Equity, Total 29.124 22.047 15.989
    Total Liabilities & Shareholders’ Equity 43673.2 41769.8 38838.5
    Total Common Shares Outstanding 11903.2 11933.2 11933.2
    Property/Plant/Equipment, Total - Gross 15009.1 14201.4 13039.5
    Accumulated Depreciation, Total -4971.83 -4619.31 -4229.35
    Long Term Debt 19.9 28.95 11.79
    Cash & Equivalents 10465.3
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line 7582.26 6847.1 6391.02 4626.16 3792.18
    Cash From Operating Activities 7627.06 4636.63 6739.61 3783.9 3795.29
    Cash From Operating Activities 955.461 838.391 791.967 673.641 594.006
    Amortization 90.352 25.361 15.121 17.954 20.142
    Non-Cash Items -464.546 -545.12 -1077.66 -149.795 -131.162
    Cash Taxes Paid 1334.58 1141.18 1061.02 866.825 636.074
    Cash Interest Paid 13.451 7.105 10.322 32.426 74.337
    Changes in Working Capital -536.464 -2529.1 619.16 -1384.06 -479.872
    Cash From Investing Activities -6795.98 -637.326 -2129.51 -2457.19 -3627.87
    Capital Expenditures -2722.69 -1758.45 -1576.61 -2122.67 -2156.86
    Other Investing Cash Flow Items, Total -4073.29 1121.12 -552.907 -334.521 -1471.01
    Cash From Financing Activities -1904.07 -2196.61 -1470.98 -1545.54 -151.387
    Financing Cash Flow Items 342.338 -20.164 -19.961 -1590.8 1497.52
    Total Cash Dividends Paid -2096.96 -1690.76 -1527.69 -965.385 -782.875
    Issuance (Retirement) of Stock, Net -14.211 -263.512 0 1122.79 -83.433
    Issuance (Retirement) of Debt, Net -135.239 -222.167 76.679 -112.153 -782.598
    Foreign Exchange Effects 14.136 -2.444 2.101 1.455 3.014
    Net Change in Cash -1058.86 1800.25 3141.22 -217.377 19.049
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Cash From Operating Activities 7627.06 4257.13
    Cash Interest Paid 13.451 9.722
    Changes in Working Capital 7627.06 4257.13
    Cash From Investing Activities -6795.98 -5703.2
    Capital Expenditures -2722.69 -970.212
    Other Investing Cash Flow Items, Total -4073.29 -4732.98
    Cash From Financing Activities -1904.07 -758.222
    Financing Cash Flow Items 342.338 1.426
    Total Cash Dividends Paid -2096.96 -1019.16
    Issuance (Retirement) of Debt, Net -135.239 273.728
    Foreign Exchange Effects 14.136 9.592
    Net Change in Cash -1058.86 -2194.69
    Cash Taxes Paid
    Issuance (Retirement) of Stock, Net -14.211 -14.211
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Cai (Dong Chen) Individual Investor 13.2783 1580541200 0 2023-07-14 LOW
    Massive Giant Group Ltd. Corporation 10.2395 1218834470 0 2023-07-14 LOW
    Common Success International Ltd. Corporation 6.1227 728796313 0 2022-12-31
    UBS Asset Management (Hong Kong) Limited Investment Advisor 4.8723 579963670 4154000 2023-10-19 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 2.7965 332869110 -8482000 2023-10-13 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.4112 287010955 720000 2023-09-30 LOW
    First Sentier Investors (Hong Kong) Limited Investment Advisor 1.9542 232607441 0 2023-07-31 LOW
    Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 1.1239 133781812 -11247505 2022-12-31 LOW
    Bosera Asset Management Co., Ltd. Investment Advisor 0.9117 108516000 38734000 2023-06-30 MED
    State Street Global Advisors Asia Ltd. Investment Advisor/Hedge Fund 0.8414 100159631 2941263 2023-09-30 LOW
    BlackRock Asset Management Ireland Limited Investment Advisor 0.8024 95512893 -1162000 2023-10-13 LOW
    BlackRock Advisors (UK) Limited Investment Advisor/Hedge Fund 0.791 94153373 -1338000 2023-09-30 LOW
    Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 0.6897 82097360 424000 2023-09-30 LOW
    Caisse de Depot et Placement du Quebec Pension Fund 0.5929 70568837 -24043283 2022-12-31 LOW
    Hang Seng Investment Management Ltd. Investment Advisor 0.5768 68663594 6425512 2023-09-30 LOW
    Nuveen LLC Pension Fund 0.5683 67642450 3210248 2023-09-30 LOW
    Harvest Fund Management Co., Ltd. Investment Advisor 0.5669 67478040 14808000 2023-06-30 MED
    California State Teachers Retirement System Pension Fund 0.5135 61119044 4562352 2022-06-30 LOW
    Zhong Ou Asset Management Co., Ltd. Investment Advisor 0.4479 53310000 -14704000 2023-06-30 MED
    BlackRock Investment Management (UK) Ltd. Investment Advisor/Hedge Fund 0.4204 50046943 -19426968 2023-01-31 LOW

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    CSPC Pharmaceutical Company profile

    About CSPC Pharmaceutical Group Ltd

    CSPC Pharmaceutical Group Limited is an investment holding company principally engaged in the manufacture and sales of pharmaceutical products. The Company sells its products under the brand of CSPS. The Company has four business segments: Finished Drugs, Antibiotics (intermediates and bulk drugs), Vitamin C (bulk drugs) and Caffeine and Others (bulk drugs). All these segments are engaged in the manufacture and sales of related pharmaceutical products. The finished drugs include the antibiotics, cardio-cerebrovascular drugs, diabetes drugs, neurology drugs, oncology drugs and traditional Chinese medicines. The Company is also engaged in the provision of pharmaceutical research and development services, as well as the processing of sewage and pharmaceutical by-products through its subsidiaries.

    Financial summary

    BRIEF: For the fiscal year ended 31 December 2021, CSPC Pharmaceutical Group Ltd revenues increased 12% to RMB27.87B. Net income increased 9% to RMB5.61B. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was partially offset by Selling and distribution expenses increase of 11% to RMB10.44B (expense), Research and development expenses increase of 19% to RMB3.43B (expense).

    Industry: Pharmaceuticals (NEC)

    黃河大道路226號
    SHIJIAZHUANG
    HEBEI 050035
    CN

    Income Statement

    • Annual
    • Quarterly

    News

    December RBA preview: no move expected at the final meeting of 2023

    The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

    14:47, 4 December 2023

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    12:39, 30 November 2023

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023

    People also watch

    Oil - Crude

    71.02 Price
    -0.630% 1D Chg, %
    Long position overnight fee -0.0204%
    Short position overnight fee -0.0015%
    Overnight fee time 22:00 (UTC)
    Spread 0.030

    BTC/USD

    42,397.55 Price
    -3.370% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 22:00 (UTC)
    Spread 106.00

    Gold

    1,996.62 Price
    -0.490% 1D Chg, %
    Long position overnight fee -0.0199%
    Short position overnight fee 0.0117%
    Overnight fee time 22:00 (UTC)
    Spread 0.30

    US100

    16,059.50 Price
    -0.140% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 22:00 (UTC)
    Spread 1.8

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading